Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 8, 2026 | Venture Capital & Startup Funding Roundup, September 8, 2026: Accel, Atomico, Bessemer, General Catalyst, Thrive Capital, Y Combinator & More | Venture capital’s clearest signal today isn’t AI by itself. It is capital moving toward systems that control scarce physical capacity, regulated workflows, or hard-to-replicate operating networks. In just the past 12 hours, investors poured... |
| Dec 5, 2023 | Seattle Children’s spins out BrainChild Bio, a startup developing therapies for incurable brain cancers | BrainChild Bio will rent space in the Seattle Children’s building Building Cure. The structure opened in downtown Seattle in 2019. The startup will occupy part of the 10th floor, which is also home to Seattle Children’s Therapeutics. (Seatt... |
| BrainChild Bio | “BrainChild Bio is a kids-first, clinical-stage biotechnology company harnessing the power of CAR-T cell technology for tumors in the central nervous system (CNS), prioritizing pediatrics with plans to expand our technology platform to adul... |
Reviews 0
FAQ about BrainChild Bio
What has the press written about BrainChild Bio?
Parsers VC has collected 4 articles mentioning BrainChild Bio, among them “Venture Capital & Startup Funding Roundup, September 8, 2026: Accel, Atomico, Bessemer, General Catalyst, Thrive Capital, Y Combinator & More” (Sep 8, 2026) and “Seattle Children’s spins out BrainChild Bio, a startup developing therapies for incurable brain cancers” (Dec 5, 2023).
Is BrainChild Bio still active?
Yes, BrainChild Bio is active; its latest activity on Parsers VC dates from Sep 10, 2026.